Mattia Belloni

Articles by Mattia Belloni

Stock.adobe.com

Re-Thinking Oncology HTAs: the (Growing) Role of Non-OS Endpoints

ByAnaïs Frappé,Mattia Belloni

June 23rd 2025

Cancer patients’ journeys are complex and the benefit of a drug goes well beyond survival, even in cases of incurable and/or metastatic cancer.

Latest Updated Articles

Re-Thinking Oncology HTAs: the (Growing) Role of Non-OS Endpoints
June 23rd 2025

Trending on PharmExec

2026 Pharm Exec Top 50 Companies

What Does the Operational Reality of Reshoring Actually Look Like?

Henlius Enters $322 Million Strategic Collaboration with Sandoz

Your Questions Answered: Emerging Trends in Pharma Funding and M&A

AI at the FDA: Efficiency, Oversight, and Open Questions